US Critical Metals Corp
USCM
Three Valley Copper Corp
TVC.H
Revive Therapeutics Ltd
RVV
Global Hemp Group Inc
GHG
E2Gold Inc
ETU
(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 85.92%-24.1K | 61.45%-105.24K | 121.74%86.94K | -14.67%-1.43M | 24.26%-588.86K | -125.57%-171.08K | 65.54%-273.02K | -14.63%-399.92K | 21.11%-1.25M | -315.83%-777.49K |
Net income from continuing operations | -5.08%-801.31K | 8.80%-988.25K | -4.62%-1.1M | -84.87%-4.88M | -61.76%-1.98M | -321.52%-762.55K | -26.20%-1.08M | -16.77%-1.05M | 19.30%-2.64M | -26.85%-1.23M |
Operating gains losses | 210.52%69K | 888.39%69.41K | 152.94%66.97K | 118.60%65.94K | 570.56%263.69K | 44.49%-62.43K | 90.31%-8.8K | -32.97%-126.51K | -14,098.28%-354.53K | 24.01%-56.04K |
Depreciation and amortization | 13.81%300.33K | 15.71%305.33K | 45.88%390.91K | 18.90%1.24M | 46.68%442.95K | -2.44%263.88K | 12.07%263.88K | 14.59%267.96K | 10.81%1.04M | 28.16%302K |
Asset impairment expenditure | ---- | ---- | ---- | --265.95K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | -48.49%2.06K | 374.20%42.56K | -77.49%8.64K | -2.52%107.49K | 532.50%56.14K | -65.96%4K | -67.20%8.98K | -38.38%38.37K | -65.84%110.27K | -62.65%8.88K |
Other non cashItems | 148.23%197.14K | 125.83%307.55K | 75.25%177.27K | 53.95%548.23K | 140.23%231.47K | -34.97%79.42K | 104.52%136.19K | 42.41%101.15K | 58.01%356.1K | 275.13%96.35K |
Change In working capital | -31.94%208.68K | -38.66%251.71K | 21.46%446.86K | 416.43%1.22M | 38.03%135.74K | 831.52%306.6K | 338.32%410.37K | 32.68%367.91K | 53.17%236.36K | -81.16%98.35K |
-Change in receivables | -122.00%-5.57K | -234.24%-10.96K | -95.06%538 | 260.61%44.01K | 97.95%-395 | 45.11%25.33K | 127.64%8.17K | 179.01%10.9K | -248.85%-27.4K | -525.43%-19.23K |
-Change in inventory | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 52.30%-85.89K | -107.09%-17.8K |
-Change in prepaid assets | 1,744.16%32.54K | 201.25%33.11K | 441.36%103.67K | -298.67%-90.24K | -157.14%-118.4K | -106.74%-1.98K | -71.50%10.99K | -18.65%19.15K | 205.06%45.42K | 26.68%-46.05K |
-Change in payables and accrued expense | -35.84%181.72K | -41.32%229.56K | 1.42%342.66K | 316.42%1.27M | 40.30%254.54K | 2,549.14%283.25K | 328.66%391.21K | 19.30%337.86K | -21.08%304.23K | -44.86%181.42K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 85.92%-24.1K | 95.72%-11.69K | 98.35%-6.61K | -14.67%-1.43M | 24.26%-588.86K | -125.57%-171.08K | 65.54%-273.02K | -14.63%-399.92K | 21.11%-1.25M | -315.83%-777.49K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 67.50%-74.61K | 4.57%-173.44K | 90.32%-25.14K | 48.39%-999.18K | 41.04%-328.2K | 52.14%-229.54K | 46.46%-181.75K | 53.65%-259.69K | 7.84%-1.94M | 33.03%-556.69K |
Net PPE purchase and sale | --0 | --0 | --0 | --0 | 105.39%368 | 100.00%-1 | 100.00%1 | 98.82%-368 | -94.68%-133.46K | -464.30%-6.83K |
Net intangibles purchas and sale | 67.50%-74.61K | 4.57%-173.44K | 90.31%-25.14K | 44.57%-999.18K | 40.25%-328.57K | 46.07%-229.54K | 39.01%-181.75K | 50.98%-259.32K | 11.30%-1.8M | 34.00%-549.86K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 67.50%-74.61K | 4.57%-173.44K | 90.32%-25.14K | 48.39%-999.18K | 41.04%-328.2K | 52.14%-229.54K | 46.46%-181.75K | 53.65%-259.69K | 7.84%-1.94M | 33.03%-556.69K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 3.09%325.48K | -73.03%171.61K | -105.79%-35.86K | -17.82%2.45M | -33.75%874.28K | 241.10%315.74K | -45.25%636.27K | -13.70%619.64K | 238.46%2.98M | 27.69%1.32M |
Net issuance payments of debt | 3.09%325.48K | -77.74%141.61K | -116.52%-85.86K | 471.93%2.15M | 157.67%674.28K | -59.92%315.74K | 853.02%636.27K | 567.34%519.64K | 9.87%-576.97K | -602.38%-1.17M |
Net common stock issuance | ---- | ---- | --0 | -87.77%300K | -85.33%200K | ---- | ---- | -68.67%100K | 61.43%2.45M | 13.65%1.36M |
Net other financing activities | ---- | ---- | --50K | ---- | ---- | ---- | ---- | ---- | --1.1M | --1.13M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 3.09%325.48K | -73.03%171.61K | -105.79%-35.86K | -17.82%2.45M | -33.75%874.28K | 241.10%315.74K | -45.25%636.27K | -13.70%619.64K | 238.46%2.98M | 27.69%1.32M |
Net cash flow | ||||||||||
Beginning cash position | -88.27%27.84K | -23.88%41.71K | 15.69%108.98K | -68.77%94.2K | 26.57%152.21K | 68.36%237.22K | -50.42%54.79K | -68.77%94.2K | -90.57%301.6K | -57.55%120.26K |
Current changes in cash | 367.17%226.78K | -107.45%-13.52K | -69.17%-67.62K | 106.62%13.87K | -196.61%-42.79K | -147.56%-84.88K | 497.38%181.51K | 79.08%-39.97K | 92.53%-209.42K | -194.21%-14.43K |
Effect of exchange rate changes | 420.66%388 | -138.26%-352 | -39.21%338 | -54.73%913 | 96.20%-442 | -100.89%-121 | --920 | --556 | 102.21%2.02K | -484.75%-11.63K |
End cash Position | 67.53%255K | -88.27%27.84K | -23.88%41.71K | 15.69%108.98K | 15.69%108.98K | 26.57%152.21K | 68.36%237.22K | -50.42%54.79K | -68.77%94.2K | -68.77%94.2K |
Free cash from | 75.36%-98.71K | 59.29%-185.13K | 95.19%-31.75K | 23.65%-2.43M | 31.26%-917.06K | -311.44%-400.62K | 59.82%-454.76K | 27.44%-659.61K | 13.54%-3.19M | -31.03%-1.33M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.